Inés Ferrer-Cairols, Teresa Montoliu, Isabel Crespo-Sanmiguel, Matias M Pulopulos, Vanesa Hidalgo, Enriqueta Gómez, Rogelio López-Cuevas, Ana Cuevas, Núria Martín, Miguel Baquero, Alicia Salvador
{"title":"轻度认知障碍患者的抑郁和自杀风险:阿尔茨海默病生物标志物的作用","authors":"Inés Ferrer-Cairols, Teresa Montoliu, Isabel Crespo-Sanmiguel, Matias M Pulopulos, Vanesa Hidalgo, Enriqueta Gómez, Rogelio López-Cuevas, Ana Cuevas, Núria Martín, Miguel Baquero, Alicia Salvador","doi":"10.7334/psicothema2022.103","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with depression and mild cognitive impairment (MCI) are at greater risk of developing dementia. Depression involves a higher risk of suicidal ideation (SI) and suicide attempts (SA). Biomarkers of Alzheimer's Disease (AD) could help to clarify the role of depression and SI in AD.</p><p><strong>Method: </strong>Fifty-nine participants aged > 50 with criteria of MCI positive (MCI-AD) (n=22) and negative (MCI-Non AD) (n=24) AD and healthy controls (HC) (n=13) were evaluated. We used the Geriatric Depression Scale (GDS-30) and the GDS-SI factor to measure depression and indirect risk for suicide, respectively. Additionally, AD biomarkers such as amyloid-ß (Aß), hyperphosphorilated tau (P-tau), and total tau (T-tau) in cerebrospinal fluid (CSF) were analyzed.</p><p><strong>Results: </strong>No significant differences between the groups were found in depression. However, in the MCI-AD group, lower P-tau and T-tau levels were related to higher GDS-SI scores, suggesting that MCI-AD patients with lower AD pathology are at a higher risk of suicide.</p><p><strong>Conclusions: </strong>The result highlights the importance of considering SI in the initial phases of AD, and the potential role of AD biomarkers in early detection of symptoms.</p>","PeriodicalId":48179,"journal":{"name":"Psicothema","volume":"34 4","pages":"553-561"},"PeriodicalIF":3.2000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Depression and Suicide Risk in Mild Cognitive Impairment: The Role of Alzheimer's Disease Biomarkers.\",\"authors\":\"Inés Ferrer-Cairols, Teresa Montoliu, Isabel Crespo-Sanmiguel, Matias M Pulopulos, Vanesa Hidalgo, Enriqueta Gómez, Rogelio López-Cuevas, Ana Cuevas, Núria Martín, Miguel Baquero, Alicia Salvador\",\"doi\":\"10.7334/psicothema2022.103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients with depression and mild cognitive impairment (MCI) are at greater risk of developing dementia. Depression involves a higher risk of suicidal ideation (SI) and suicide attempts (SA). Biomarkers of Alzheimer's Disease (AD) could help to clarify the role of depression and SI in AD.</p><p><strong>Method: </strong>Fifty-nine participants aged > 50 with criteria of MCI positive (MCI-AD) (n=22) and negative (MCI-Non AD) (n=24) AD and healthy controls (HC) (n=13) were evaluated. We used the Geriatric Depression Scale (GDS-30) and the GDS-SI factor to measure depression and indirect risk for suicide, respectively. Additionally, AD biomarkers such as amyloid-ß (Aß), hyperphosphorilated tau (P-tau), and total tau (T-tau) in cerebrospinal fluid (CSF) were analyzed.</p><p><strong>Results: </strong>No significant differences between the groups were found in depression. However, in the MCI-AD group, lower P-tau and T-tau levels were related to higher GDS-SI scores, suggesting that MCI-AD patients with lower AD pathology are at a higher risk of suicide.</p><p><strong>Conclusions: </strong>The result highlights the importance of considering SI in the initial phases of AD, and the potential role of AD biomarkers in early detection of symptoms.</p>\",\"PeriodicalId\":48179,\"journal\":{\"name\":\"Psicothema\",\"volume\":\"34 4\",\"pages\":\"553-561\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psicothema\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.7334/psicothema2022.103\",\"RegionNum\":2,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHOLOGY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psicothema","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.7334/psicothema2022.103","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, MULTIDISCIPLINARY","Score":null,"Total":0}
Depression and Suicide Risk in Mild Cognitive Impairment: The Role of Alzheimer's Disease Biomarkers.
Background: Patients with depression and mild cognitive impairment (MCI) are at greater risk of developing dementia. Depression involves a higher risk of suicidal ideation (SI) and suicide attempts (SA). Biomarkers of Alzheimer's Disease (AD) could help to clarify the role of depression and SI in AD.
Method: Fifty-nine participants aged > 50 with criteria of MCI positive (MCI-AD) (n=22) and negative (MCI-Non AD) (n=24) AD and healthy controls (HC) (n=13) were evaluated. We used the Geriatric Depression Scale (GDS-30) and the GDS-SI factor to measure depression and indirect risk for suicide, respectively. Additionally, AD biomarkers such as amyloid-ß (Aß), hyperphosphorilated tau (P-tau), and total tau (T-tau) in cerebrospinal fluid (CSF) were analyzed.
Results: No significant differences between the groups were found in depression. However, in the MCI-AD group, lower P-tau and T-tau levels were related to higher GDS-SI scores, suggesting that MCI-AD patients with lower AD pathology are at a higher risk of suicide.
Conclusions: The result highlights the importance of considering SI in the initial phases of AD, and the potential role of AD biomarkers in early detection of symptoms.
期刊介绍：
La revista Psicothema fue fundada en Asturias en 1989 y está editada conjuntamente por la Facultad y el Departamento de Psicología de la Universidad de Oviedo y el Colegio Oficial de Psicólogos del Principado de Asturias. Publica cuatro números al año. Se admiten trabajos tanto de investigación básica como aplicada, pertenecientes a cualquier ámbito de la Psicología, que previamente a su publicación son evaluados anónimamente por revisores externos. Psicothema está incluida en las bases de datos nacionales e internacionales más relevantes, entre las que cabe destacar Psychological Abstracts, Current Contents y MEDLINE/Index Medicus, entre otras. Además, figura en las listas de Factor de Impacto del Journal Citation Reports. Psicothema es una revista abierta a cualquier enfoque u orientación psicológica que venga avalada por la fuerza de los datos y los argumentos, y en la que encuentran acomodo todos los autores que sean capaces de convencer a los revisores de que sus manuscritos tienen la calidad para ser publicados. Psicothema es una revista de acceso abierto lo que significa que todo el contenido está a disposición de cualquier usuario o institución sin cargo alguno. Los usuarios pueden leer, descargar, copiar, distribuir, imprimir, buscar, o realizar enlaces a los textos completos de esta revista sin pedir permiso previo al editor o al autor, siempre y cuando la fuente original sea referenciada. Para acervos y repositorios, se prefiere que la cobertura se realice mediante enlaces a la propia web de Psicothema. Nos parece que una apuesta decidida por la calidad es el mejor modo de servir a nuestros lectores, cuyas sugerencias siempre serán bienvenidas.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
